Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells

Sato, Katsutoshi; Padgaonkar, Amol A.; Baker, Stacey J.; Cosenza, Stephen C.; Rechkoblit, Olga; Subbaiah, D.R.C. Venkata; Domingo-Domenech, Josep; Bartkowski, Alison; Port, Elisa R.; Aggarwal, Aneel K.; Reddy, M.V. Ramana; Irie, Hanna Y.; Reddy, E. Premkumar

doi:10.1038/s41467-021-24878-z

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells

Journal Article · 01 August 2021 · Nat. Commun.

DOI:https://doi.org/10.1038/s41467-021-24878-z· OSTI ID:1829875

Sato, Katsutoshi; Padgaonkar, Amol A.; Baker, Stacey J.; Cosenza, Stephen C.; Rechkoblit, Olga; Subbaiah, D.R.C. Venkata; Domingo-Domenech, Josep; Bartkowski, Alison; Port, Elisa R.; Aggarwal, Aneel K.; Reddy, M.V. Ramana; Irie, Hanna Y.; Reddy, E. Premkumar

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH); OTHER

OSTI ID:: 1829875

Journal Information:: Nat. Commun., Vol. 12

Country of Publication:: United States

Language:: ENGLISH

References (70)

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment Garrido-Castro, Ana C.; Lin, Nancy U.; Polyak, Kornelia Cancer Discovery, Vol. 9, Issue 2 https://doi.org/10.1158/2159-8290.CD-18-1177	journal	January 2019
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer Liedtke, Cornelia; Mazouni, Chafika; Hess, Kenneth R. Journal of Clinical Oncology, Vol. 26, Issue 8 https://doi.org/10.1200/JCO.2007.14.4147	journal	March 2008
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes von Minckwitz, Gunter; Untch, Michael; Blohmer, Jens-Uwe Journal of Clinical Oncology, Vol. 30, Issue 15 https://doi.org/10.1200/JCO.2011.38.8595	journal	May 2012
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness Lee, Kha-Liang; Kuo, Yung-Che; Ho, Yuan-Soon Cancers, Vol. 11, Issue 9 https://doi.org/10.3390/cancers11091334	journal	September 2019
Prospective identification of tumorigenic breast cancer cells Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A. Proceedings of the National Academy of Sciences, Vol. 100, Issue 7 https://doi.org/10.1073/pnas.0530291100	journal	March 2003
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome Ginestier, Christophe; Hur, Min Hee; Charafe-Jauffret, Emmanuelle Cell Stem Cell, Vol. 1, Issue 5 https://doi.org/10.1016/j.stem.2007.08.014	journal	November 2007
CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity Montgomery, Nicola; Hill, Ashleigh; McFarlane, Suzanne Breast Cancer Research, Vol. 14, Issue 3 https://doi.org/10.1186/bcr3199	journal	May 2012
Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer So, Jae Young; Smolarek, Amanda K.; Salerno, David M. PLoS ONE, Vol. 8, Issue 1 https://doi.org/10.1371/journal.pone.0054020	journal	January 2013
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC) Ma, Fei; Li, Huihui; Li, Yiqun Medicine, Vol. 96, Issue 14 https://doi.org/10.1097/MD.0000000000006561	journal	January 2017
ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype Zhong, Ying; Shen, Songjie; Zhou, Yidong Medical Oncology, Vol. 31, Issue 3 https://doi.org/10.1007/s12032-014-0864-0	journal	February 2014
Using Functional Genetics to Understand Breast Cancer Biology Ashworth, A.; Bernards, R. Cold Spring Harbor Perspectives in Biology, Vol. 2, Issue 7 https://doi.org/10.1101/cshperspect.a003327	journal	June 2010
Utilizing RNA interference to enhance cancer drug discovery Iorns, Elizabeth; Lord, Christopher J.; Turner, Nicholas Nature Reviews Drug Discovery, Vol. 6, Issue 7 https://doi.org/10.1038/nrd2355	journal	July 2007
Targeting the cancer kinome through polypharmacology Knight, Zachary A.; Lin, Henry; Shokat, Kevan M. Nature Reviews Cancer, Vol. 10, Issue 2 https://doi.org/10.1038/nrc2787	journal	February 2010
Protein kinase CK2 phosphorylates and upregulates Akt/PKB Di Maira, G.; Salvi, M.; Arrigoni, G. Cell Death & Differentiation, Vol. 12, Issue 6 https://doi.org/10.1038/sj.cdd.4401604	journal	April 2005
Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells Di Maira, Giovanni; Brustolon, Francesca; Pinna, Lorenzo A. Cellular and Molecular Life Sciences, Vol. 66, Issue 20 https://doi.org/10.1007/s00018-009-0108-1	journal	August 2009
The Down syndrome-related protein kinase DYRK1A phosphorylates p27 ^Kip1 and Cyclin D1 and induces cell cycle exit and neuronal differentiation Soppa, Ulf; Schumacher, Julian; Florencio Ortiz, Victoria Cell Cycle, Vol. 13, Issue 13 https://doi.org/10.4161/cc.29104	journal	May 2014
Wnt/ -Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway Jho, E. -h.; Zhang, T.; Domon, C. Molecular and Cellular Biology, Vol. 22, Issue 4 https://doi.org/10.1128/MCB.22.4.1172-1183.2002	journal	February 2002
The kinase TNIK is an essential activator of Wnt target genes Mahmoudi, Tokameh; Li, Vivian S. W.; Ng, Ser Sue The EMBO Journal, Vol. 28, Issue 21 https://doi.org/10.1038/emboj.2009.285	journal	October 2009
TNIK inhibition abrogates colorectal cancer stemness Masuda, Mari; Uno, Yuko; Ohbayashi, Naomi Nature Communications, Vol. 7, Issue 1 https://doi.org/10.1038/ncomms12586	journal	August 2016
Structural basis of CX-4945 binding to human protein kinase CK2 Ferguson, Andrew D.; Sheth, Payal R.; Basso, Andrea D. FEBS Letters, Vol. 585, Issue 1 https://doi.org/10.1016/j.febslet.2010.11.019	journal	November 2010
Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme Niefind, K. The EMBO Journal, Vol. 20, Issue 19 https://doi.org/10.1093/emboj/20.19.5320	journal	October 2001
Protein Kinase CK2 Is an Inhibitor of the Neuronal Cdk5 Kinase Lim, Anthony C. B.; Hou, Zhibo; Goh, Choon-Peng Journal of Biological Chemistry, Vol. 279, Issue 45 https://doi.org/10.1074/jbc.M404760200	journal	November 2004
Genome-wide survey of protein kinases required for cell cycle progression Bettencourt-Dias, M.; Giet, R.; Sinka, R. Nature, Vol. 432, Issue 7020 https://doi.org/10.1038/nature03160	journal	December 2004
Specific binding of protein kinase CK2 catalytic subunits to tubulin Faust, Michael; Schuster, Norbert; Montenarh, Mathias FEBS Letters, Vol. 462, Issue 1-2 https://doi.org/10.1016/S0014-5793(99)01492-1	journal	November 1999
Direct Regulation of Microtubule Dynamics by Protein Kinase CK2 Lim, Anthony C. B.; Tiu, Sock-Yeen; Li, Qing Journal of Biological Chemistry, Vol. 279, Issue 6 https://doi.org/10.1074/jbc.M310563200	journal	February 2004
Cancer stem cells and oncology therapeutics Al-Hajj, Muhammad Current Opinion in Oncology, Vol. 19, Issue 1 https://doi.org/10.1097/CCO.0b013e328011a8d6	journal	January 2007
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells Liu, Rui; Wang, Xinhao; Chen, Grace Y. New England Journal of Medicine, Vol. 356, Issue 3 https://doi.org/10.1056/NEJMoa063994	journal	January 2007
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Visvader, Jane E.; Lindeman, Geoffrey J. Nature Reviews Cancer, Vol. 8, Issue 10 https://doi.org/10.1038/nrc2499	journal	September 2008
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications Shibue, Tsukasa; Weinberg, Robert A. Nature Reviews Clinical Oncology, Vol. 14, Issue 10 https://doi.org/10.1038/nrclinonc.2017.44	journal	April 2017
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy Fillmore, Christine M.; Kuperwasser, Charlotte Breast Cancer Research, Vol. 10, Issue 2 https://doi.org/10.1186/bcr1982	journal	March 2008
Cancer stem cell markers in common cancers – therapeutic implications Klonisch, Thomas; Wiechec, Emilia; Hombach-Klonisch, Sabine Trends in Molecular Medicine, Vol. 14, Issue 10 https://doi.org/10.1016/j.molmed.2008.08.003	journal	October 2008
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors Ben-Porath, Ittai; Thomson, Matthew W.; Carey, Vincent J. Nature Genetics, Vol. 40, Issue 5 https://doi.org/10.1038/ng.127	journal	April 2008
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival Silva, I. A.; Bai, S.; McLean, K. Cancer Research, Vol. 71, Issue 11 https://doi.org/10.1158/0008-5472.CAN-10-3175	journal	April 2011
Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma Liebscher, Catarina Alisa; Prinzler, Judith; Sinn, Bruno Valentin Human Pathology, Vol. 44, Issue 8 https://doi.org/10.1016/j.humpath.2012.12.016	journal	August 2013
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype Kida, Kumiko; Ishikawa, Takashi; Yamada, Akimitsu Breast Cancer Research and Treatment, Vol. 156, Issue 2 https://doi.org/10.1007/s10549-016-3738-7	journal	March 2016
DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis Fernández-Martínez, P.; Zahonero, C.; Sánchez-Gómez, P. Molecular & Cellular Oncology, Vol. 2, Issue 1 https://doi.org/10.4161/23723548.2014.970048	journal	December 2014
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells Gao, Jingchun; Zheng, Zhong; Rawal, Bhupendra Cancer Biology & Therapy, Vol. 8, Issue 17 https://doi.org/10.4161/cbt.8.17.9322	journal	September 2009
CK2 Controls the Recruitment of Wnt Regulators to Target Genes In Vivo Wang, Song; Jones, Katherine A. Current Biology, Vol. 16, Issue 22 https://doi.org/10.1016/j.cub.2006.09.034	journal	November 2006
CK2 Phosphorylation of the Armadillo Repeat Region of β-Catenin Potentiates Wnt Signaling Song, Diane H.; Dominguez, Isabel; Mizuno, Junko Journal of Biological Chemistry, Vol. 278, Issue 26 https://doi.org/10.1074/jbc.M212260200	journal	June 2003
Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription Tapia, J. C.; Torres, V. A.; Rodriguez, D. A. Proceedings of the National Academy of Sciences, Vol. 103, Issue 41 https://doi.org/10.1073/pnas.0606845103	journal	September 2006
Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells Zhang, Shulin; Wang, Yucheng; Mao, Jian-Hua PLoS ONE, Vol. 7, Issue 6 https://doi.org/10.1371/journal.pone.0038996	journal	June 2012
Inhibition of CK 2α down‐regulates Notch1 signalling in lung cancer cells Zhang, Shulin; Long, Hao; Yang, Yi‐Lin Journal of Cellular and Molecular Medicine, Vol. 17, Issue 7 https://doi.org/10.1111/jcmm.12068	journal	May 2013
Self-renewal signaling pathways in breast cancer stem cells Nalla, Lakshmi Vineela; Kalia, Kiran; Khairnar, Amit The International Journal of Biochemistry & Cell Biology, Vol. 107 https://doi.org/10.1016/j.biocel.2018.12.017	journal	February 2019
Global Screening of CK2 Kinase Substrates by an Integrated Phosphoproteomics Workflow Bian, Yangyang; Ye, Mingliang; Wang, Chunli Scientific Reports, Vol. 3, Issue 1 https://doi.org/10.1038/srep03460	journal	December 2013
Identification of Candidate Casein Kinase 2 Substrates in Mitosis by Quantitative Phosphoproteomics Rusin, Scott F.; Adamo, Mark E.; Kettenbach, Arminja N. Frontiers in Cell and Developmental Biology, Vol. 5 https://doi.org/10.3389/fcell.2017.00097	journal	November 2017
The emerging CK2 interactome: insights into the regulation and functions of CK2 Gyenis, Laszlo; Litchfield, David W. Molecular and Cellular Biochemistry, Vol. 316, Issue 1-2 https://doi.org/10.1007/s11010-008-9830-5	journal	June 2008
Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays Giusiano, Sophie; Cochet, Claude; Filhol, Odile European Journal of Cancer, Vol. 47, Issue 5 https://doi.org/10.1016/j.ejca.2010.11.028	journal	March 2011
Nuclear localization of protein kinase CK2 catalytic subunit (CK2α) is associated with poor prognostic factors in human prostate cancer Laramas, Mathieu; Pasquier, Dominique; Filhol, Odile European Journal of Cancer, Vol. 43, Issue 5 https://doi.org/10.1016/j.ejca.2006.11.021	journal	March 2007
Protein kinase CK2 in mammary gland tumorigenesis Landesman-Bollag, Esther; Romieu-Mourez, Raphaëlle; Song, Diane H. Oncogene, Vol. 20, Issue 25 https://doi.org/10.1038/sj.onc.1204411	journal	May 2001
Protein Kinase CK2 in Health and Disease: CK2 and its role in Wnt and NF-κB signaling: Linking development and cancer Dominguez, I.; Sonenshein, G. E.; Seldin, D. C. Cellular and Molecular Life Sciences, Vol. 66, Issue 11-12 https://doi.org/10.1007/s00018-009-9153-z	journal	April 2009
Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation McElhinny, J. A.; Trushin, S. A.; Bren, G. D. Molecular and Cellular Biology, Vol. 16, Issue 3 https://doi.org/10.1128/MCB.16.3.899	journal	March 1996
Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II Wang, Dan; Westerheide, Sandy D.; Hanson, Julie L. Journal of Biological Chemistry, Vol. 275, Issue 42 https://doi.org/10.1074/jbc.M001358200	journal	October 2000
Casein Kinase 2α Regulates Multidrug Resistance-Associated Protein 1 Function via Phosphorylation of Thr249 Stolarczyk, Elzbieta I.; Reiling, Cassandra J.; Pickin, Kerry A. Molecular Pharmacology, Vol. 82, Issue 3 https://doi.org/10.1124/mol.112.078295	journal	June 2012
CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy Siddiqui-Jain, Adam; Bliesath, Joshua; Macalino, Diwata Molecular Cancer Therapeutics, Vol. 11, Issue 4 https://doi.org/10.1158/1535-7163.MCT-11-0613	journal	January 2012
Inhibition of casein kinase 2 prevents growth of human osteosarcoma Takahashi, Kengo; Setoguchi, Takao; Tsuru, Arisa Oncology Reports, Vol. 37, Issue 2 https://doi.org/10.3892/or.2016.5310	journal	December 2016
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells Rowse, Amber L.; Gibson, Sara A.; Meares, Gordon P. Journal of Neuro-Oncology, Vol. 132, Issue 2 https://doi.org/10.1007/s11060-017-2378-z	journal	February 2017
Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway Nitta, R. T.; Gholamin, S.; Feroze, A. H. Oncogene, Vol. 34, Issue 28 https://doi.org/10.1038/onc.2014.299	journal	September 2014
Dosage of Dyrk1a Shifts Cells within a p21-Cyclin D1 Signaling Map to Control the Decision to Enter the Cell Cycle Chen, Jia-Yun; Lin, Jia-Ren; Tsai, Feng-Chiao Molecular Cell, Vol. 52, Issue 1 https://doi.org/10.1016/j.molcel.2013.09.009	journal	October 2013
DYRK 1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model Kurabayashi, Nobuhiro; Nguyen, Minh Dang; Sanada, Kamon EMBO reports, Vol. 16, Issue 11 https://doi.org/10.15252/embr.201540374	journal	September 2015
Regulation of Gli1 Transcriptional Activity in the Nucleus by Dyrk1 Mao, Junhao; Maye, Peter; Kogerman, Priit Journal of Biological Chemistry, Vol. 277, Issue 38 https://doi.org/10.1074/jbc.M206743200	journal	September 2002
Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer Masuda, Mari; Sawa, Masaaki; Yamada, Tesshi Pharmacology & Therapeutics, Vol. 156 https://doi.org/10.1016/j.pharmthera.2015.10.009	journal	December 2015
The Germinal Center Kinase TNIK Is Required for Canonical NF-κB and JNK Signaling in B-Cells by the EBV Oncoprotein LMP1 and the CD40 Receptor Shkoda, Anna; Town, Jennifer A.; Griese, Janine PLoS Biology, Vol. 10, Issue 8 https://doi.org/10.1371/journal.pbio.1001376	journal	August 2012
Inhibition of casein kinase 2 blocks G₂/M transition in early embryo mitosis but not in oocyte meiosis in mouse Lin, Fei; Cao, Shi-Bing; Ma, Xue-Shan Journal of Reproduction and Development, Vol. 63, Issue 3 https://doi.org/10.1262/jrd.2016-064	journal	January 2017
CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival Ponce, Daniela P.; Yefi, Roger; Cabello, Pablo Molecular and Cellular Biochemistry, Vol. 356, Issue 1-2 https://doi.org/10.1007/s11010-011-0965-4	journal	July 2011
Abstract B146: A novel TNIK inhibitor potently downregulates cancer stem cell population through attenuation of Wnt signaling Uno, Yuko; Moriyama, Hideki; Kashimoto, Shigeki Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA, Therapeutic Agents: Small-Molecule Kinase Inhibitors https://doi.org/10.1158/1535-7163.TARG-17-B146	conference	January 2018
Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer Pierre, Fabrice; Chua, Peter C.; O’Brien, Sean E. Molecular and Cellular Biochemistry, Vol. 356, Issue 1-2 https://doi.org/10.1007/s11010-011-0956-5	journal	July 2011
Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice Hashimoto, Ayumi; Gao, Chan; Mastio, Jerome Cancer Research, Vol. 78, Issue 19 https://doi.org/10.1158/0008-5472.CAN-18-1229	journal	August 2018
Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia Padgaonkar, Amol; Rechkoblit, Olga; Vasquez-Del Carpio, Rodgrigo Oncotarget, Vol. 9, Issue 102 https://doi.org/10.18632/oncotarget.26514	journal	December 2018
Antitumor Activity of Pyridocarbazole and Benzopyridoindole Derivatives that Inhibit Protein Kinase CK2 Prudent, Renaud; Moucadel, Virginie; Nguyen, Chi-Hung Cancer Research, Vol. 70, Issue 23 https://doi.org/10.1158/0008-5472.CAN-10-0917	journal	November 2010
Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas Divakar, S. K. A.; Ramana Reddy, M. V.; Cosenza, S. C. Leukemia, Vol. 30, Issue 1 https://doi.org/10.1038/leu.2015.185	journal	July 2015

Similar Records

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells

Journal Article · 2021 · Nat. Commun. · OSTI ID:1831258

Sato, Katsutoshi; Padgaonkar, Amol A.; Baker, Stacey J.; +10 more

Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis

Journal Article · 2019 · Molecular Cancer Therapeutics · OSTI ID:1609775

Karginova, Olga; Weekley, Claire M.; Raoul, Akila; +5 more

Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition

Journal Article · 2018 · Experimental Cell Research · OSTI ID:23082637

Chen, Jia-Hong; Kuo, Kuang-Tai; Bamodu, Oluwaseun Adebayo; +4 more

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells

Citation Formats

References (70)

Similar Records

Related Subjects